Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the

Yonglun Kong1,2, Weijing Feng1,3,4, Xiaoduo Zhao2

  • 1Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China.

Theranostics
|September 15, 2020
PubMed

Insights

Statins may improve kidney water handling in chronic kidney disease by reducing cholesterol-induced inflammation and promoting aquaporin-2 (AQP2) expression, despite controversial effects on kidney function. This study investigated statin effects on renal AQP2 and NLRP3 inflammasome.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) is linked to dyslipidemia, with statins recommended for cardiovascular risk but controversial for kidney disease progression.
  • The impact of statins on renal water handling and kidney disease progression remains unclear.

Purpose of the Study:

  • To investigate statin treatment effects on renal water handling in patients and animal models with high-fat diet-induced dyslipidemia.
  • To examine the relationship between serum cholesterol, aquaporin-2 (AQP2), and the NLRP3 inflammasome in kidney disease.

Main Methods:

  • Retrospective analysis of patient kidney biopsy data to assess AQP2 and ASC protein expression.
  • In vivo studies using Nlrp3-deficient mice and 5/6 nephrectomized rats on a high-fat diet, treated with statins.
  • In vitro experiments to evaluate cholesterol and statin effects on NLRP3 inflammasome components and AQP2.

Main Results:

  • Serum cholesterol negatively correlated with estimated glomerular filtration rate (eGFR) and kidney AQP2 expression in patients; statins abolished this correlation without affecting eGFR.
  • High-fat diet decreased AQP2 and increased urine output in mice, an effect attenuated by Nlrp3 deficiency.
  • Atorvastatin decreased urine output and increased AQP2 in rats; in vitro, cholesterol upregulated NLRP3 components and decreased AQP2, effects prevented by statins via ASC speck degradation.

Conclusions:

  • Serum cholesterol negatively impacts kidney AQP2 expression in CKD patients.
  • Statins ameliorate cholesterol-induced renal inflammation by promoting ASC speck degradation and improving aquaporin expression in high-fat diet animal models.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225
Inflammation01:38

Inflammation

Overview
60.4K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
557
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
156